What is Avalo Therapeutics's book value per share?

Avalo Therapeutics (AVTX) reported book value per share of $3.40 in Q1 2026.

How has Avalo Therapeutics's book value per share changed year-over-year?

Avalo Therapeutics's book value per share decreased by 70.9% year-over-year, from $11.66 to $3.40.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Avalo Therapeutics AVTX Book value per share

Book value per share at other companies

Eli LillyLLY

$34.82+98.9%

AbbVieABBV

-$3.75-568%

XencorXNCR

$6.85-21.1%

AbCellera Biologics Inc.ABCL

$3.10-9.9%

AnaptysBio, Inc.ANAB

$0.44-60.0%

Absci CorporationABSI

$1.12-29.6%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

total stockholders equity/weighted shares diluted=$3.40

Based on the most recent quarter.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's book value per share?: Avalo Therapeutics (AVTX) reported book value per share of $3.40 in Q1 2026.
How has Avalo Therapeutics's book value per share changed year-over-year?: Avalo Therapeutics's book value per share decreased by 70.9% year-over-year, from $11.66 to $3.40.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.